Has Timothy Canty, MD received payments from drug or device companies?

Yes. Drug and device makers reported $14,269 in general payments to Timothy Canty, MD across 300 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Timothy Canty, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Timothy Canty, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Timothy Canty, MD

Pain Medicine · New York, NYNPI 1043201452

Payments from drug & device makers

$14,269in general payments, 2019–2025

Across 300 payments — averaging $47.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$6K
Scilex Pharmaceuticals Inc.$1K
Spinal Simplicity, LLC$908
Nevro Corp.$873
Medtronic$867
Relievant Medsystems, Inc.$781
plus $4K from 35 others

What the payments were for

Travel & lodging$3,16322%
Food & beverage$11,10678%
Gifts$00%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	66	$5,869
Scilex Pharmaceuticals Inc.	57	$1,119
Spinal Simplicity, LLC	9	$908
Nevro Corp.	20	$873
Medtronic(2 entities)	27	$867
Relievant Medsystems, Inc.	10	$781
MML US, Inc.	8	$492
Neuronetics, Inc.	4	$361
Si-bone, Inc.	4	$356
Abbott	7	$313
Biotronik NRO, Inc.	5	$256
Collegium Pharmaceutical, Inc.	14	$249
Vertos Medical, Inc.	7	$213
Painteq LLC	3	$172
Kowa Pharmaceuticals America, Inc.	6	$157
Curonix LLC	1	$126
Saluda Medical Americas, Inc.	1	$117
Amgen	7	$115
AbbVie(2 entities)	5	$109
SPR Therapeutics, Inc	4	$97
Nalu Medical, Inc.	4	$94
Averitas Pharma Inc.	1	$68
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$68
Fujifilm Sonosite, Inc.	1	$52
Globus Medical	2	$43
GRT US Holding, Inc.	2	$40
Daiichi Sankyo Inc.	3	$37
Shionogi Inc	2	$33
Virtus Pharmaceuticals LLC	2	$31
Johnson & Johnson	2	$30
Ipsen Biopharmaceuticals, Inc	1	$25
Zyla Life Sciences, Inc.	2	$25
Zimmer Biomet	1	$25
AstraZeneca	1	$24
Bioventus LLC	1	$23
MDD US Operations, LLC	1	$22
Orthofix Medical, Inc.	1	$20
Supernus Pharmaceuticals, Inc.	1	$18
Stimwave Technologies Incorporated	1	$15
Biodelivery Sciences International, Inc.	1	$13
Medline Industries LP	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SUPERION$1,385
GENERAL PAIN MANAGEMENT$1,056
WAVEWRITER ALPHA$923
HA MINUTEMAN G3-R$742
ReActiv8$385
Intracept$367
SPECTRA WAVEWRITER$289
NEUROSTAR TMS THERAPY SYSTEM$278
INTELLIS$159
Senza$143
INFINION$142
Omnia$133
Prospera$129
iFuse Implant$127
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$126
Senza Spinal Cord Stimulation System$124
PAINTEQ$122
Evoke$117
mild Device Kit$103

How this compares

$14,269 in reported general payments places this provider in the 85th percentile of 503 pain medicine providers in New York.

See all pain medicine providers in New York →

Medicare billing

Part B allowed, 2024

$125,323

Medicare patients

113

Services billed

922

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	263	$3,450
Pregabalin	81	$2,960
Gabapentin	285	$2,738
Lidocaine	28	$2,375
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	103	$2,240
Celecoxib	80	$2,050
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	118	$1,590
Tizanidine Hcl	150	$1,000
Duloxetine Hcl	53	$857
Cyclobenzaprine Hcl	282	$828
Fentanyl	16	$796
Meloxicam	169	$473
Ibuprofen	79	$449
Diclofenac Potassium	30	$437
Naproxen	101	$410

Paid to pharmacies, not to this prescriber.

Other pain medicine in New York

Amitabh GulatiNew York$627K
David SpinnerNew York$391K
Eric LeeNew York$156K
Christopher GhariboNew York$94K
Randa JaafarNew York$87K
Boris LeybelNew York$58K
Chirag ShahNew York$48K
Annie Layno-MosesNew York$29K
Raj MurthyNew York$24K
David CassagnolNew York$22K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →